Medikinet Retard (Methylphenidate Hydrochloride)

Methylphenidate blocks the reuptake of dopamine and norepinephrine, increasing their levels in the brain. This heightened neurotransmitter activity enhances signaling in regions that control attention, impulse control, and arousal, which alleviates the core symptoms of ADHD and improves alertness in narcolepsy.

The specific dose of Medikinet Retard is individualized by a qualified prescriber based on the patient’s age, condition severity, and response to therapy. Only a healthcare professional can determine the appropriate dosage and titration schedule.

Safety of methylphenidate during pregnancy or lactation has not been definitively established. Healthcare providers weigh potential benefits against possible risks before prescribing to pregnant or nursing individuals, and alternative treatments may be considered when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Medikinet Retard is an extended‑release formulation of methylphenidate, offering once‑daily dosing and a smoother plasma concentration curve compared with immediate‑release stimulants. Compared with amphetamine‑based products, it has a different side‑effect profile and may be preferred when clinicians seek a methylphenidate‑based option.

Store Medikinet Retard tablets at ambient temperature, preferably below 25 °C, in the original container to protect from moisture and light. Keep the medication out of reach of children and do not use if the packaging is damaged.

Medikinet Retard is taken orally, usually once daily in the morning with or without food, as directed by the prescriber. The tablet should be swallowed whole; it must not be split, chewed, or crushed to maintain the extended‑release properties.

Serious risks include cardiovascular events such as hypertension, arrhythmias, or chest pain, as well as psychiatric effects like new or worsening psychosis, severe anxiety, or manic episodes. Rarely, an allergic reaction may occur, presenting with rash, swelling, or breathing difficulties.

Medikinet Retard is contraindicated in individuals with known hypersensitivity to methylphenidate or any tablet components, those with severe cardiovascular disorders, glaucoma, or a history of psychosis not controlled by medication. It should also be avoided in patients currently taking monoamine oxidase inhibitors.